Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02674789
Other study ID # NL54333.081.15
Secondary ID
Status Active, not recruiting
Phase N/A
First received December 9, 2015
Last updated February 1, 2016
Start date December 2015
Est. completion date March 2016

Study information

Verified date February 2016
Source Wageningen University
Contact n/a
Is FDA regulated No
Health authority Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study type Interventional

Clinical Trial Summary

Ionized magnesium variation is measured during a normal day and again during a day with an exercise protocol of 90 minutes.


Description:

Magnesium is an essential micronutrient for health and exercise performance. Deficiencies are common, especially in case of insufficient diets. Athletes are a population at risk of magnesium deficiency, as they can have strong nutritional (dis)believes and increased losses through sweat. That is why monitoring magnesium status in athletes is very important. Ionized magnesium is the active form of total magnesium, this value might be even more important than total magnesium. However, whether ionized magnesium is influenced by day variation is not clear yet. In addition: one bout of exercise can change magnesium status and probably ionized magnesium status. For people active in sports it is important to be aware of this variation in magnesium status, to prevent the diagnosis of false inadequate magnesium status. Therefore it is the aim of this proposal to determine whether ionized magnesium varies within one day and whether it changes after an acute bout of exercise.

Objective:

The main objective is to investigate whether ionized magnesium concentration varies during one day, and whether it is changed after one bout of exercise

Study design:

This will be a cross-over design. With screening and preliminary tests before the exercise test day and the non-exercise test day. The order in which exercise day and non-exercise day will be done, will be randomly divided between the participants.

Intervention:

A rest day and an exercise day At exercise day: an exercise test of 90 min at 70% of VO2max. Blood samples are taken at set time points during rest day and exercise day


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 18
Est. completion date March 2016
Est. primary completion date March 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Age: 18 - 45 y

- BMI: 18.5 - 25

- Minimal of 5 hours of training per week, for at least 2 years

- Used to bike, at least 5 hours per week in high season

- No Mg and / or Ca supplementation during study

- No blood donation, during or in the 6 weeks preliminary the study

- Suitable veins

- No chronic medication, with the exception of paracetamol and or birth control

- No antibiotics in the month preliminary the study

- Good health

- Serum Mg > 0.7 mmol/L

- Willing to give blood

- Able to be present and participate at all test days

Exclusion Criteria:

- Chronical illness

- Use of medication with the exception of paracetamol and or birth control

- Mg and or Ca supplementation use

- Inadequate Mg intake (according to FFQ)

- Working at Human Nutrition

- Wageningen University Msc thesis or internship at Human Nutrition

- Participating in other scientific research (with the exception of EetMeetWeet)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise protocol
70% VO2max bike ergometer test for 90 minutes

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Wageningen University Gelderse Vallei Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Blood samples analyzed on the pHOx analyzer for their ionized magnesium concentration blood Blood samples are collected at 7 set time points during one day No
Secondary blood samples are analyzed on the Dimension Vista 1500 of Siemens for their total magnesium concentration blood plasma Blood samples are collected at 7 set time points during one day No
See also
  Status Clinical Trial Phase
Completed NCT04130620 - Validation of the Magnesium Muscle Stretch Test
Completed NCT01593501 - How Does Magnesium Status Influence Calcium Homeostasis? Phase 4
Recruiting NCT04942119 - Impact of Long-term Serum Magnesium and Potassium Levels Optimization and Multifactorial Adherence Intervention on the Progression of Diabetic Kidney Disease. N/A
Recruiting NCT05149820 - Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments Phase 4
Completed NCT02032186 - A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy Phase 3
Completed NCT04216836 - One Week of Magnesium Supplementation Lowers IL-6, Perceived Pain and Increases Post Exercise Blood Glucose in Response to Downhill Running N/A
Completed NCT03353636 - Bioavailability of Magnesium Supplements N/A
Completed NCT04972344 - Preoperative Ionized Magnesium Assessment
Completed NCT02719925 - Mineral Water Rich in Magnesium and Perceived Stress in Healthy Consumers N/A
Completed NCT05630339 - Magnesium and Vitamin D Combination for Post-COVID Syndrome N/A
Completed NCT03554668 - Systemic Inflammatory Response: Thiamine and Magnesium Status (Sir TaM Study)
Recruiting NCT05271838 - Protein and Magnesium in Ulcerative Colitis N/A
Completed NCT03134417 - Magnesium and Vitamin D Supplementation and Cardiometabolic Outcomes N/A
Completed NCT03466528 - Alcohol: Thiamine and or Magnesium 1 Phase 2/Phase 3
Recruiting NCT03840226 - The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients Phase 3
Terminated NCT03471481 - Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy